会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 26. 发明授权
    • Prophylactic and therapeutic composition for circulatory disorders and
method of treatment
    • 循环障碍的预防和治疗组合物及治疗方法
    • US4857542A
    • 1989-08-15
    • US122516
    • 1987-11-19
    • Hiroyoshi NishiToshiaki WatanabeSatoshi YukiYasuhiro MorinakaKatsuhiko IsekiHiroko Sakurai
    • Hiroyoshi NishiToshiaki WatanabeSatoshi YukiYasuhiro MorinakaKatsuhiko IsekiHiroko Sakurai
    • C07D231/20C07D231/22C07D231/26C07D231/28C07D231/56
    • C07D231/56C07D231/20C07D231/22C07D231/26C07D231/28
    • A prophylactic and therapeutic agent for circulatory disorders, comprising a pyrazolone derivative of the formula: ##STR1## wherein R.sub.1 represents a hydrogen atom, an aryl group, an alkyl group having 1 to 5 carbon atoms or an alkoxycarbonylalkyl group having a total carbon number of 3 to 6; R.sub.2 represents a hydrogen atom, an aryloxy group, an arylmercapto group, an alkyl group having 1 to 5 carbon atoms or hydroxyalkyl group having 1 to 3 carbon atoms; or R.sub.1 and R.sub.2 taken together represent an alkylene group having 3 to 5 carbon atoms; R.sub.3 represents a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, a cycloalkyl group having 5 to 7 carbon atoms, a hydroxyalkyl group having 1 to 3 carbon atoms, a benzyl group, a naphthyl group, or a phenyl group which is unsubstituted or substituted with 1 to 3 substituents which are the same or different selected from the group consisting of alkyl groups having 1 to 5 carbon atoms, alkoxy groups having 1 to 5 carbon atoms, hydroxyalkyl groups having 1 to 3 carbon atoms, alkoxycarbonyl groups having total carbon number of 2 to 5, alkylmercapto groups having 1 to 3 carbon atoms, alkylamino groups having 1 to 4 carbon atoms, dialkylamino groups having total carbon number of 2 to 8, halogen atoms, trifluoromethyl group, carboxyl group, cyano group, hydroxyl group, nitro group, amino group and acetamide group,or a pharmaceutically acceptable salt thereof as an acitve ingredient.The agent of the present invention is useful as a prophylactic and therapeutic agent for circulatory disorders, particularly as an inhibitor agaisnt lipid peroxidation and/or an agent for normalizing cerebral dysfunctions.
    • 一种循环系统疾病的预防和治疗剂,其包含下式的吡唑啉酮衍生物:其中R 1表示氢原子,芳基,具有1至5个碳原子的烷基或具有总碳数的烷氧基羰基烷基 3至6; R2表示氢原子,芳氧基,芳基巯基,碳原子数1〜5的烷基或碳原子数1〜3的羟烷基。 或R 1和R 2一起表示具有3至5个碳原子的亚烷基; R3表示氢原子,碳原子数1〜5的烷基,碳原子数5〜7的环烷基,碳原子数1〜3的羟烷基,苄基,萘基或苯基, 未取代或被1〜3个选自碳原子数1〜5的烷基,碳原子数为1〜5的烷氧基,碳原子数1〜3的烷氧基,碳原子数1〜3的烷氧基,烷氧基羰基, 总碳数为2至5,具有1至3个碳原子的烷基巯基,具有1至4个碳原子的烷基氨基,总碳数为2至8的二烷基氨基,卤素原子,三氟甲基,羧基,氰基,羟基 基团,硝基,氨基和乙酰胺基,或其药学上可接受的盐作为acitve成分。 本发明的药剂可用作循环障碍的预防和治疗剂,特别是作为抑制剂脂质过氧化作用的抑制剂和/或用于使脑功能障碍正常化的药剂。
    • 27. 发明授权
    • .gamma.-butyrolactone derivatives, process for preparing the same and
immunomodulating compositions containing the same as active ingredients
    • γ-丁内酯衍生物,其制备方法和含有该活性成分的免疫调节组合物
    • US4613613A
    • 1986-09-23
    • US647979
    • 1984-09-06
    • Tomei OguriYasuhiro MorinakaShuichiro Kadowaki
    • Tomei OguriYasuhiro MorinakaShuichiro Kadowaki
    • A61K31/365A61P29/00C07D307/33C07D307/58C07D307/94A61K31/34C07D307/10C07D307/26
    • C07D307/33C07D307/58C07D307/94
    • A .gamma.-butyrolactone derivative represented by the following formula: ##STR1## wherein R.sup.1 represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a phenyl group; R.sup.2 and R.sup.3 may be the same or different and each represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group, a phenyl group, a phenyl group substituted with a substituent selected from the group consisting of a halogen atom, an alkoxy group, a nitro group, an amino group, an alkyl group having 1-4 carbon atoms, a nitrile group and an alkoxycarbonyl group; R.sup.2 and R.sup.3 may be linked to form an alkylene group having 4-6 carbon atoms; X represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group or a substituent represented by the formula ##STR2## (wherein R.sup.4 represents a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group, a phenyl group or a phenyl group substituted with a substituent selected from the group consisting of a halogen atom, an alkoxy group, a nitro group, an alkylthio group, a nitrile group, an alkoxycarbonyl group and an alkyl group having 1-4 carbon atoms) or a salt thereof. The invention also provides an immunomodulating composition wherein the aforedescribed compound is the active component.
    • 由下式表示的γ-丁内酯衍生物:其中R1表示氢原子,具有1-8个碳原子的直链或支链烷基,苯基; R2和R3可以相同或不同,各自表示氢原子,具有1-8个碳原子的直链或支链烷基,具有3-10个碳原子的环烷基,苄基,苯基,苯基 被选自卤素原子,烷氧基,硝基,氨基,具有1-4个碳原子的烷基,腈基和烷氧羰基组成的组中的取代基取代; R2和R3可以连接形成具有4-6个碳原子的亚烷基; X表示氢原子,具有1-8个碳原子的直链或支链烷基,具有3-10个碳原子的环烷基,苄基或由式“IMAGE”表示的取代基(其中R4表示直链或支链 具有1-8个碳原子的烷基,具有3-10个碳原子的环烷基,苄基,苯基或被选自卤素原子,烷氧基,硝基的取代基取代的苯基 基团,烷硫基,腈基,烷氧基羰基和具有1-4个碳原子的烷基)或其盐。 本发明还提供一种免疫调节组合物,其中上述化合物是活性成分。